Title : Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

Pub. Date : 2014 Nov

PMID : 25440788






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Finally, the combination of aspirin, clopidogrel, and low-dose rivaroxaban has recently been approved by the European Medicines Agency (but not the Food and Drug Administration) for secondary prevention after ACS. Rivaroxaban 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens